Applications of L-Histidine Hydrochloride in Industrial Manufacturing

As an established manufacturer of L-Histidine Hydrochloride, we supply this high-purity amino acid salt for direct integration into specialized downstream sectors. Below, you will find detailed industrial application segments, each outlining regulatory demand, formulation ratios, and unique process considerations for the targeted use cases.

1. Biopharmaceutical Cell Culture Media Production

Our L-Histidine Hydrochloride serves as a critical amino acid component in the formulation of cell culture media for the large-scale propagation of mammalian cells. Biopharma producers rely on its consistent purity and bioavailability for supporting cell growth, especially in the upstream production of monoclonal antibodies and recombinant proteins. Manufacturing specifications require precise adjustment based on the metabolic profiles of different cell lines such as CHO or HEK293. Stringent in-process QC tracks purity, endotoxin level, and microbial safety at intake and every batch addition.

Industry compliance standards

• USP–NF (United States Pharmacopeia–National Formulary)
• European Pharmacopoeia (Ph. Eur.)
• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (FDA cGMP for Finished Pharmaceuticals)

Typical usage ratio

• 0.02–0.12 g/L, adjusted by final cell line requirements and basal vs. feed medium formulation

Downstream process integration

• Direct addition to basal and feed media during initial compounding or subsequent nutrient supplementation stages

Final product types

• Recombinant therapeutic proteins
• Monoclonal antibodies
• Viral vaccines
• Bioprocessed enzymes

2. Food and Nutritional Supplement Manufacturing

Food and nutrition manufacturers use L-Histidine Hydrochloride as a labeled amino acid ingredient in dietary supplements, sports nutrition blends, and medical food formulations. Producers monitor batch traceability and allergen control under food-grade GMP systems. The source amino acid must fulfill both compositional and process safety audits, especially when formulating fortified blends for infants or clinical nutrition markets. Formulators calculate inclusion levels based on target amino acid profiles and regional regulatory limits, with documentation required for every added nutrient.

Industry compliance standards

• GB 14880 (National Standard for Food Additives, China)
• 21 CFR Part 172 (FDA Food Additives Permitted for Direct Addition to Food)
• EFSA (European Food Safety Authority) Novel Food Regulation
• ISO 22000 Food Safety Management

Typical usage ratio

• 0.1–2.0 % by weight in finished dietary supplement blends, within national legal maxima for individual amino acids

Downstream process integration

• Premix blending with other micronutrients; granulation or direct compression into tablets, capsules, or powder products

Final product types

• Essential amino acid supplements
• Infant formula and medical nutrition powders
• Protein and recovery drinks
• Functional nutrition bars

3. Parenteral and Enteral Nutrition Solutions

Producers of clinical parenteral and enteral nutrition solutions adopt L-Histidine Hydrochloride to meet precise physiological amino acid profiles for patient support. Strict pharma-grade sourcing and microbiological safety measures govern every step, with real-time monitoring of sterility and particulate load. Pharmacists and formulators calculate amino acid concentrations according to current standards for specific patient groups such as pediatrics or renal impairment. All lots undergo line-specific dissolution and filtration steps to control final injection or infusion quality.

Industry compliance standards

• USP–NF Monograph for Parenteral Nutrition
• EMA Guidelines on Excipients in the Dossier for Application
• WHO Guidelines for Safe Preparation of Parenteral Nutrition
• GMP Annex 1 (EU–GMP for Sterile Medicinal Products)

Typical usage ratio

• 0.2–1.5 g/L in parenteral nutrition solutions, based on clinical dosing parameters

Downstream process integration

• Sterile compounding in aqueous solution tanks; filtration and aseptic filling into IV bags or vials

Final product types

• Total parenteral nutrition (TPN) solutions
• Specialized amino acid infusions
• Intravenous clinical nutrition compounds
• Pediatric enteral feeding solutions

4. Diagnostic Reagents and Biochemical Research Kits

In life sciences and diagnostics, component suppliers use L-Histidine Hydrochloride as a buffer constituent and substrate in various analytical and calibration reagents. Major kit manufacturers value its defined molecular weight, predictable reactivity under controlled pH, and compatibility with protein labeling or enzyme activity assays. Every lot is QC-checked for trace metal content and dissolved residues. Batch-specific certificates accompany shipments for regulated research use and diagnostic platforms.

Industry compliance standards

• ISO 13485 Medical Devices—Quality Management Systems
• REACH Regulation (EC) No. 1907/2006 for laboratory chemicals
• Good Laboratory Practice (GLP), OECD
• RoHS compliance when used for components of electronic diagnostic devices

Typical usage ratio

• 0.01–0.2 mol/L in buffer systems and standard solutions, tailored for each analytic protocol

Downstream process integration

• Dissolution into analytical buffers; formulation of calibration controls or enzymatic substrates during reagent kit assembly

Final product types

• ELISA and PCR reagent kits
• Clinical biochemistry analyzers
• Protein labeling kits
• Buffer solutions for in vitro diagnostics

5. Veterinary Pharmaceutical Preparations

Veterinary medicine compounders include L-Histidine Hydrochloride for amino acid supplementation in injectable formulations and oral animal feeds. Regulatory reviews confirm the raw material’s origin, absence of restricted residues, and conformance with veterinary pharmacopeias. Dosing levels adjust for animal type, age, and the intended route of administration, with rigorous homogeneity tests in compounded bulk and final packs.

Industry compliance standards

• Pharmacopoeia Europaea (Ph. Eur. Veterinary)
• VICH GL9 Good Manufacturing Practice for Veterinary Medicinal Products
• US FDA Center for Veterinary Medicine (CVM) guidelines
• Food Safety Modernization Act (FSMA) for animal feed

Typical usage ratio

• 0.05–0.3 g/kg in feed supplements and 0.05–0.18 g/100 mL in injectables, calculated by indicated species and administration route

Downstream process integration

• Wet granulation into feed additive premixes or solubilization prior to aseptic injection vial filling

Final product types

• Veterinary amino acid injections
• Animal feed premixes
• Amino acid boluses
• Livestock nutritional drench